Oxford BioMedica (GB:OXB) has released an update.
Oxford Biomedica PLC has announced the issuance of 5,201,107 new shares, comprising 4.9% of its enlarged share capital, to facilitate a £16.9 million investment by Institut Mérieux’s subsidiary TSGH SAS. This move follows the strategic acquisition of ABL Europe SAS by Oxford Biomedica, bolstering its EU bioprocessing and manufacturing capabilities. Post-admission, Institut Mérieux will hold a 10.9% stake in the company, becoming a major shareholder and reinforcing its commitment to Oxford Biomedica’s growth strategy.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
